High levels of SOX5 decrease proliferative capacity of human B Cells, but permit plasmablast differentiation

6Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Currently very little is known about the differential expression and function of the transcription factor SOX5 during B cell maturation. We identified two new splice variants of SOX5 in human B cells, encoding the known L-SOX5B isoform and a new shorter isoform L-SOX5F. The SOX5 transcripts are highly expressed during late stages of B-cell differentiation, including atypical memory B cells, activated CD21low B cells and germinal center B cells of tonsils. In tonsillar sections SOX5 expression was predominantly polarized to centrocytes within the light zone. After in vitro stimulation, SOX5 expression was downregulated during proliferation while high expression levels were permissible for plasmablast differentiation. Overexpression of L-SOX5F in human primary B lymphocytes resulted in reduced proliferation, less survival of CD138neg B cells, but comparable numbers of CD138+CD38hi plasmablasts compared to control cells. Thus, our findings describe for the first time a functional role of SOX5 during late B cell development reducing the proliferative capacity and thus potentially affecting the differentiation of B cells during the germinal center response. © 2014 Rakhmanov et al.

Cite

CITATION STYLE

APA

Rakhmanov, M., Sic, H., Kienzler, A. K., Fischer, B., Rizzi, M., Seidl, M., … Warnatz, K. (2014). High levels of SOX5 decrease proliferative capacity of human B Cells, but permit plasmablast differentiation. PLoS ONE, 9(6). https://doi.org/10.1371/journal.pone.0100328

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free